Liabilities, Current of Can-Fite BioPharma Ltd. from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Can-Fite BioPharma Ltd. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Liabilities, Current for the quarter ending 30 Jun 2025 was $2,120,000, a 6.7% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,120,000 +$133,000 +6.7% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 $2,052,000 +$32,000 +1.6% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 $1,987,000 -$246,000 -11% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $2,020,000 -$482,000 -19% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q2 2023 $2,233,000 +$80,000 +3.7% 30 Jun 2023 6-K 31 Aug 2023 2023 Q2
Q4 2022 $2,502,000 -$228,000 -8.4% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 $2,153,000 -$206,000 -8.7% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 $2,730,000 +$1,461,000 +115% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $2,359,000 +$858,000 +57% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $1,269,000 -$2,002,000 -61% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 $1,501,000 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q4 2019 $3,271,000 +$152,000 +4.9% 31 Dec 2019 20-F 25 Mar 2021 2020 FY
Q4 2018 $3,119,000 31 Dec 2018 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.